Knowledge Center
Article / Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016
Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled Hovione to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.
Related links
Also in the Knowledge Center
/ Jan 01, 2012
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions
Read more
Scientific Article
/ Jan 01, 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Read more
Scientific Article
Scientific Article